Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

 
Thumbnail
Date
2017
Author
Director, Moderna Medical
Metadata
Show full item record
Abstract
The clinical study will assess the safety, tolerability, and immunogenicity of mRNA-1325 in healthy adult subjects. Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: Parallel Assignment Masking: Participant, Investigator Primary Purpose: Prevention Official Title: A Phase 1/2, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of mRNA 1325 Zika Vaccine in Healthy Adults in a Non-endemic Zika Region
URI
https://clinicaltrials.gov/ct2/show/NCT03014089
Collections